ALBO - Albireo Pharma Inc. (ALBO) CEO Ron Cooper on Q1 2022 Results - Earnings Call Transcript

Albireo Pharma, Inc. (ALBO) Q1 2022 Earnings Conference Call May 16, 2022 16:30 ET Company Participants Hans Vitzthum - Managing Director-LifeSci Advisors, LLC Ron Cooper - President & Chief Executive Officer Pamela Stephenson - Chief Commercial Officer Simon Harford - Chief Financial Officer Conference Call Participants Ritu Baral - Cowen Eun Yang - Jefferies Brian Skorney - Baird Andreas Argyrides - Wedbush Securities Ed Arce - H.C. Wainwright Presentation Operator Good afternoon, and welcome to the Albireo Pharma First Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] Please note that this conference is being recorded. I would now turn the call over to your host, Hans Vitzthum, Managing Director of LifeSci Advisors. Thank you. You may begin. Hans Vitzthum Thank you, operator, and good afternoon, everyone. Thank you for joining today's call. This afternoon,

For further details see:

Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q1 2022 Results - Earnings Call Transcript